GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU
Technology
E-053-2019
Patent ID
E-053-2019-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
62/803,468
IC
NCI
Date Filed
Date Issued
Patent PDF